Comprehensive analysis of human monocyte subsets using full-spectrum flow cytometry and hierarchical marker

Chao Li1, Maozhi Xiao1, Suxia Geng1

  • 1Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.

PubMed

Insights

This study introduces a new flow cytometry method to precisely identify monocyte subsets in peripheral blood. This advances understanding of monocyte roles in cancer and improves personalized immunotherapies.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Monocytes play critical roles in the tumor microenvironment, influencing cancer progression and treatment response.
  • Understanding distinct monocyte subsets is essential for developing effective cancer immunotherapies.

Purpose of the Study:

  • To develop and validate a novel, high-dimensional flow cytometry method for comprehensive peripheral immune system phenotyping.
  • To refine the identification and characterization of classical, intermediate, and non-classical monocyte subsets.

Main Methods:

  • Utilized four 20-color flow cytometry panels for detailed monocyte subset analysis.
  • Applied advanced dimensionality reduction techniques, including t-distributed stochastic neighbor embedding (tSNE) and FlowSom.
  • Profiled monocytes by assessing 50 unique cell surface markers related to immune functions.

Main Results:

  • Achieved significantly refined identification of monocyte subsets.
  • Revealed distinct marker expression patterns associated with tumor progression.
  • Identified key markers related to monocyte activation, differentiation, and immune checkpoint regulation.

Conclusions:

  • The novel panel enhances the accuracy of monocyte phenotyping, crucial for personalized immunotherapies.
  • Findings provide new avenues for targeted therapeutic interventions and improve diagnostic precision.
  • This approach deepens the understanding of monocyte biology in cancer, impacting checkpoint-inhibitor therapy success.
Abstract